COMMUNIQUÉS West-GlobeNewswire

Terns Pharmaceuticals Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(C)(4)
26/02/2025
FOSTER CITY, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product [...]
Lifecore Biomedical to Participate in Upcoming Investor and Industry Conferences
26/02/2025
CHASKA, Minn., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company [...]
Kura Oncology Reports Fourth Quarter and Full Year 2024 Financial Results
26/02/2025
– KOMET-001 registrational trial in R/R NPM1 -mutant AML achieved primary endpoint – – Alignment reached with FDA and EMA on key aspects of the KOMET-017 protocol including use of MRD-negative CR endpoint for potential [...]
Health Catalyst Reports Fourth Quarter and Year End 2024 Results
26/02/2025
SALT LAKE CITY, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported [...]
Revolution Medicines Reports Fourth Quarter and Full Year 2024 Financial Results and Update on Corporate Progress
26/02/2025
Company anticipates substantially completing enrollment this year in ongoing Phase 3 RASolute 302 trial of daraxonrasib in previously treated metastatic pancreatic cancer to enable expected data readout in 2026 Company [...]
scPharmaceuticals Announces Participation in Two Upcoming Investor Conferences
26/02/2025
BURLINGTON, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric [...]
MIMEDX Announces Fourth Quarter and Full Year 2024 Operating and Financial Results
26/02/2025
Net Sales Grew 7% Year-Over-Year for the Fourth Quarter and 9% for the Full Year Fourth Quarter GAAP Net Income and Earnings Per Share were $7 million and $0.05 , Respectively Fourth Quarter Adjusted EBITDA¹ was $20 [...]
Standard BioTools Reports Fourth Quarter and Full Year 2024 Financial Results
26/02/2025
SOUTH SAN FRANCISCO, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the fourth quarter and fiscal year ended [...]
Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results
26/02/2025
LEXINGTON, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel [...]
Inventiva announces the publication in Biomedicine & Pharmacotherapy of the results from a preclinical study showing improvement of portal hypertension with lanifibranor treatment
26/02/2025
The study demonstrated that lanifibranor improved Portal Hypertension (PH) in mouse models of fibrotic PH and prehepatic non-fibrotic PH Lanifibranor was observed to decrease portal pressure by improving Liver [...]
Inventiva annonce la publication dans Biomedicine & Pharmacotherapy des résultats d'une étude préclinique montrant une amélioration de l'hypertension portale avec le traitement par lanifibranor
26/02/2025
L'étude a démontré que lanifibranor améliorait l'hypertension portale (HTP) dans des modèles murins d'HTP fibrotique et d'HTP non fibrotique préhépatique Il a été observé que lanifibranor réduit la pression portale en [...]
Mdxhealth Announces Fourth Quarter and Full-Year 2024 Financial Results
26/02/2025
Fourth quarter revenue growth of 28% to $24.7 million 2024 revenue growth of 28% to $90.0 million 68% improvement in adjusted EBITDA in fourth quarter Conference call with Q&A today at 4:30 PM EST / 22:30 CET IRVINE [...]
Koios Medical and iCAD Partner to Expand AI-Powered, Multi-Modality Breast Cancer Detection Solutions at ECR 2025
26/02/2025
NASHUA, N.H. and CHICAGO, Feb. 26, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc . (NASDAQ: ICAD) a global leader in clinically proven AI-powered cancer detection solutions, and Koios Medical , a leader in AI-driven ultrasound [...]
Silo Pharma Granted U.S. Patent for Novel Intranasal Post-Traumatic Stress Disorder Treatment
26/02/2025
SARASOTA, FL, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today [...]
Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine
26/02/2025
Strategic Combination Aims to Accelerate Biomarker Identification, Enhance Drug Discovery, and Expand Precision Medicine Applications in Cancer and Beyond LOS ANGELES, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Renovaro [...]
AIM ImmunoTech Announces NYSE American Acceptance of Plan to Regain Listing Compliance
26/02/2025
OCALA, Fla., Feb. 26, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it received notice from the NYSE American (the “American”) that the American has [...]
RAMSAY SANTE :Half-year Financial Report as at end of December 2024 disposal
26/02/2025
Paris, February 26, 2025 RAMSAY SANTE Half-year Financial Report as at end of December 2024 disposal This document is available on RAMSAY SANTE Internet site : http://www.ramsaysante.fr About Ramsay Santé : Ramsay Santé [...]
RAMSAY SANTE : Mise à disposition du rapport financier semestriel au 31 décembre 2024
26/02/2025
Paris, le 26 février 2025 RAMSAY SANTE Mise à disposition du rapport financier semestriel au 31 décembre 2024 Ce document est disponible sur le site internet de RAMSAY SANTE : http://www.ramsaysante.fr A propos de [...]
RAMSAY SANTE : Half-year results at the end of December 2024
26/02/2025
PRESS RELEASE Paris, 26 th February 2025 Half-year results at the end of December 2024 Confirmed fundamentals Strengthening access to healthcare for all as a mission-driven company, Ramsay Santé, thanks to its employees [...]

Pages